Stock Analysis
Coca-Cola Europacific Partners PLC (CCEP) Stock Analysis
Coca-Cola Europacific Partners PLC (CCEP) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Coca-Cola Europacific Partners PLC (CCEP) currently has an AIQ Score of 42/100, indicating a neutral setup. Risk is the strongest factor at 52/100. Momentum is the weakest current factor at 34/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
CCEP at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $102.77 |
| AIQ Score | 42/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Sell |
| Market Cap | $47.69B |
| P/E Ratio | 21.69 |
| Forward P/E | — |
| EPS | $2.17 |
| Revenue TTM | $10.72B |
| Dividend Yield | 0.01% |
| Beta | 0.48 |
| Volume | 1.36M |
| 52-week range | $84.66-$113.67 |
| RSI 14 | 35.23 |
| 50-Day SMA | $107.01 |
| 200-Day SMA | $97.99 |
| Analyst Price Target | $110.00 |
| Next Earnings | Feb 18, 2027 |
CCEP
OverviewCCEP Stock Analysis Summary
Coca-Cola Europacific Partners PLC (CCEP) currently has an AIQ Score of 42/100, indicating a neutral setup. Risk resilience is the strongest factor at 52/100. Momentum is the weakest current factor at 34/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, CCEP has AIQ Score of 42/100 with Risk resilience base of 52/100 and fading Momentum at 34/100. Wait for component alignment before adding exposure.
Consumer Defensive · -0.11% stock move · CCEP classified in Beverages - Non-Alcoholic.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is CCEP Bullish or Bearish Right Now?
CCEP currently has a neutral overall setup. Risk Resilience is the strongest factor at 52/100, while Momentum is weakest at 34/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Analyst target implies +7.04% upside from the latest quote.
- - Value is the current constraint at 37/100.
- - Momentum is weak at 34/100.
- - Technical consensus has more sell votes than buy votes (32 vs 10).
Current Consensus
CCEP's Technical Analysis Consensus is currently Sell, with 10 buy, 3 neutral, and 32 sell votes. CCEP's 14-day RSI is 35.23, which places the stock in a weaker momentum range. CCEP's beta is 0.48, indicating lower market sensitivity than the broad market.
What Changed in CCEP?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the CCEP Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
CCEP Decision Framework
Public evidence layers, setup checks, and risk context for Coca-Cola Europacific Partners PLC.
Coca-Cola Europacific Partners PLC (CCEP) Stock Analysis
Coca-Cola Europacific Partners PLC has an AIQ Score of 42/100 in a Neutral regime. Risk is strongest at 52/100. Beta is 0.48, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | CCEP is in a Neutral AIQ regime with score 42/100. |
| Signal Conflict | The primary conflict is that risk leads at 52/100 while momentum lags at 34/100. |
| Factor Evidence | Momentum 34/100 · Value 37/100 · Quality 49/100 · Risk 52/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Risk is the strongest factor at 52/100.
Momentum is 34/100 and RSI (14) is 35.2.
CCEP is in a Neutral regime at 42/100.
Risk factor is 52/100 with beta 0.48 and annual volatility 22.68%.
Current conflict: risk leads at 52/100 while momentum lags at 34/100.
CCEP Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
CCEP Fundamentals
CCEP valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
CCEP Technical Analysis
CCEP technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
CCEP Stock Catalysts
Track CCEP earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
CCEP Dividend Analysis
CCEP dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
CCEP Financial Data
CCEP revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
CCEP Risk Analysis
CCEP volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
CCEP Stock News
CCEP stock news, market tone, recent headlines, and catalyst context.
CCEP vs Consumer Staples Peers
Current peer cohort: CCEP · CHD · CL · CLX · COST. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| CCEP Current stock | 42/100 | 37/100 | 34/100 | 52/100 | 0.59 | 22.68% | Current |
| CHD Church & Dwight | 41/100 | 28/100 | 24/100 | 55/100 | 0 | 23.29% | CCEP vs CHD |
| CL Colgate-Palmolive | 33/100 | 31/100 | 24/100 | 50/100 | 0.13 | 22.67% | CCEP vs CL |
| CLX Clorox | 30/100 | 46/100 | 19/100 | 40/100 | -1.08 | 30.91% | CCEP vs CLX |
| COST Costco Wholesale | 41/100 | 32/100 | 10/100 | 70/100 | -0.38 | 19.84% | CCEP vs COST |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching CCEP
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for CCEP
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
CCEP Stock FAQ
What is CCEP stock price today?
Coca-Cola Europacific Partners PLC's current stock price is $102.77. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is CCEP bullish or bearish right now?
CCEP's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is CCEP's market cap?
CCEP's market cap is $47.69B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is CCEP's current P/E ratio?
CCEP's current P/E ratio is 21.69 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is CCEP's RSI?
CCEP's 14-day RSI is 35.23 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is CCEP above its 50-day and 200-day moving averages?
CCEP is -3.96% from its 50-day SMA and 4.88% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is CCEP's next earnings date?
CCEP's next earnings date is currently listed as Feb 18, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does CCEP pay a dividend?
CCEP's dividend yield is 0.01% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.